Coronary Artery Bypass Grafting after Aprotinin: Are We Doing Better?
Accordingly, the usage of aprotinin should be reconsidered for treatment among cohorts of low-risk cardiac patients.
World's Largest Resource for Cardiovascular Perfusion
Accordingly, the usage of aprotinin should be reconsidered for treatment among cohorts of low-risk cardiac patients.
Kelly O’Connor from Abiomed discusses the science of hemodynamic support with VAD patients (25:06 minutes).
For HLHS and d-TGA patients, duration of mechanical ventilation and DHCA are associated with adverse neurologic outcome. Neonatal brain MRI commonly demonstrates acquired brain injuries, but the clinical impact of these abnormalities are not often seen before 2 years of age.